• Issue

    Hematological Oncology: Volume 42, Issue 4

    July 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • First Published: 31 May 2024

ORIGINAL ARTICLE

Metabolic pathway-based subtyping reveals distinct microenvironmental states associated with diffuse large B-cell lymphoma outcomes

Xiaohui Wang,  Hengqi Liu,  Yue Fei,  Zheng Song,  Xiangrui Meng,  Jingwei Yu,  Xia Liu,  Lanfang Li,  Lihua Qiu,  Zhengzi Qian,  Shiyong Zhou,  Xianhuo Wang,  Huilai Zhang, 
  • First Published: 31 May 2024

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials

Enrica Antonia Martino,  Salvatore Palmieri,  Monica Galli,  Daniele Derudas,  Roberto Mina,  Roberta Della Pepa,  Renato Zambello,  Ernesto Vigna,  Antonella Bruzzese,  Silvia Mangiacavalli,  Elena Zamagni,  Catello Califano,  Maurizio Musso,  Concetta Conticello,  Claudio Cerchione,  Giuseppe Mele,  Nicola Di Renzo,  Massimo Offidani,  Giuseppe Tarantini,  Gloria Margiotta Casaluci,  Angela Rago,  Roberto Ria,  Giuseppina Uccello,  Gregorio Barilà,  Gaetano Palumbo,  Loredana Pettine,  Iolanda Donatella Vincelli,  Marino Brunori,  Fabrizio Accardi,  Valeria Amico,  Angela Amendola,  Raffaele Fontana,  Velia Bongarzoni,  Bernardo Rossini,  Emilia Cotzia,  Alessandro Gozzetti,  Rita Rizzi,  Nicola Sgherza,  Giovanni Reddiconto,  Antonio Maroccia,  Luca Franceschini,  Giuseppe Bertuglia,  Davide Nappi,  Emiliano Barbieri,  Barbara Gamberi,  Maria Teresa Petrucci,  Francesco Di Raimondo,  Antonino Neri,  Fortunato Morabito,  Pellegrino Musto,  Massimo Gentile, 
  • First Published: 31 May 2024

A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis

Claudia Bellofiore,  Pietro Benvenuti,  Roberto Mina,  Marco Basset,  Andrea Foli,  Martina Nanci,  Mario Nuvolone,  Gianluigi Guida,  Andrea Attanasio,  Roberta Mussinelli,  Silvia Mangiacavalli,  Claudio Salvatore Cartia,  Valeria Masoni,  Michele Palumbo,  Lorenzo Cani,  Stefania Oliva,  Ugo Consoli,  Concetta Conticello,  Francesco Di Raimondo,  Luca Arcaini,  Sara Bringhen,  Giampaolo Merlini,  Giovanni Palladini,  Paolo Milani, 
  • First Published: 02 June 2024
Open Access

Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4-positive peripheral T-cell lymphoma and relapsed or refractory cutaneous T-cell lymphoma: A post-marketing surveillance in Japan

Kenji Ishitsuka,  Tomoharu Yasukawa,  Yukie Tsuji, 
  • First Published: 07 June 2024

REVIEW

Open Access

Strategies for overcoming resistance to Bruton's tyrosine kinase inhibitor zanubrutinib

Hana Dostálová,  Vladimír Kryštof, 
  • First Published: 07 June 2024

LETTER TO THE EDITOR

Clonal dynamics of Richter transformation in chronic lymphocytic leukemia

Hanyin Wang,  Shulan Tian,  Charla R. Secreto,  Sutapa Sinha,  Min Shi,  Timothy Call,  Yucai Wang,  Sameer A. Parikh,  Saad S. Kenderian,  Rong He,  Jose F. Leis,  Daniel L. VanDyke,  Eric W. Klee,  Susan L. Slager,  Esteban Braggio,  Huihuang Yan,  Wei Ding, 
  • First Published: 09 June 2024

ERRATUM

Free Access

Correction to Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience

  • First Published: 11 June 2024

ORIGINAL ARTICLE

Open Access

Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy

Danai Dima,  Utkarsh Goel,  Aishwarya Sannareddy,  Nnaemeka Ibeh,  Fauzia Ullah,  Aimaz Afrough,  Sandra Mazzoni,  Ali Mehdi,  Joslyn Rudoni,  Shahzad Raza,  Nicole De Simone,  Louis Williams,  Adeel Khan,  Aliya Rashid,  Mikhaila Rice,  Kristin Ricci,  Christy Samaras,  Jason Valent,  Larry D. Anderson Jr,  Faiz Anwer,  Gurbakhash Kaur,  Jack Khouri, 
  • First Published: 14 June 2024

ERRATUM

Free Access

Correction to Staging FDG-avidity in extranodal marginal zone lymphoma (EMZL) by disease location

  • First Published: 21 June 2024

ORIGINAL ARTICLE

TET2 regulates extranodal NK/T cell lymphoma progression through regulation of DNA methylation

Chunxiang Xiang,  Limin Gao,  Qing Tao,  Zihang Chen,  Sha Zhao,  Weiping Liu, 
  • First Published: 09 July 2024

LETTER TO THE EDITOR

Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital

Caroline Le Lan,  Aurélien Belot,  Camille Golfier,  Bérénice Audin,  Pierre Sesques,  Adeline Bernier,  Violaine Safar,  Emmanuelle Ferrant,  Anne Lazareth,  Hélène Lequeu,  Lionel Karlin,  Dana Ghergus,  Alizée Maarek,  Guillaume Aussedat,  Maryam Idlhaj,  Gilles Salles,  Fanny Cherblanc,  Emmanuel Bachy,  Hervé Ghesquieres, 
  • First Published: 11 July 2024

Prescription patterns of venetoclax in acute myeloid leukemia

Andrealuna Ucciero,  Giuseppe Traversa,  Alessia Pisterna,  Valeria Cardinali,  Sofia Sciabolacci,  Antonella Poloni,  Debora Capelli,  Gianluca Gaidano,  Andrea Patriarca,  Monia Lunghi, 
  • First Published: 11 July 2024
Open Access

Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial

Xiaohui Suo,  Zheng Fang,  Dongmei Wang,  Liyun Zhao,  Jie Liu,  Hong Li,  Xiaojun Ma,  Congcong Zhang,  Xuemei Zhao,  Rui Shi,  Yan Wu,  Zongjiu Jiao,  Jiaojie Song,  Ling Zhang,  Ling Li,  Suping Zhang,  Xinxiao Lu,  Linyu Yuan,  Sifeng Gao,  Jilei Zhang,  Kaiqi Liu,  Xingli Zhao,  Guanchen Bai,  Yingchang Mi, 
  • First Published: 23 July 2024